News & Media: All

May 23, 2017

PHE's Baumgardner Participates in Becker Friedman Institute Health Care Reform Panel

On May 22nd, PHE Senior Research Economist James Baumgardner was an invited panelist for The University of Chicago's Becker Friedman Institute for Research in Economics. On the panel, titled "The Economic Consequences of Health Care Reform," James applied his past experience as a 20-year veteran ...

May 19, 2017

Precision’s Abhishek Sharma Selected for World Heart Federation’s Emerging Leaders Program

Congratulations to Associate Health Economist Abhishek Sharma, part of Precision Health Economics’s Evidence Strategy, Generation, and Communications team, for his acceptance into the World Heart Federation’s Emerging Leaders (EL) program. The program is part of a WHF initiative to reduce ...

May 18, 2017

PHE's Bringing Our Best and Brightest to ISPOR

ISPOR's 22nd Annual International Meeting is almost here- May 20th-May 24th, 2017- and Precision Health Economics will have a very prominent presence!  

With over 25 of our experts in attendance, PHE thought leaders will be participating in a variety of scientific presentations, including a Ple ...

May 18, 2017

PHE's Seabury and Sood Promote Development of Antimicrobial Drugs in Health Affairs Blog Commentary

As global health leaders gather in Berlin from May 19-20 for the first-ever G20 Health Ministers’ meeting, one of the main topics of discussion is expected to be how to best fight the threat of antimicrobial resistance (AMR). In a new Health Affairs blog post, PHE scientific advisors Seth Sea ...

May 15, 2017

Lakdawalla, Bhattacharya and Malani in The Conversation: America Needs A ‘Do-Over’ on Medicaid Reform

PHE’s Darius Lakdawalla, along with co-authors Jay Bhattacharya and Anup Malani, offer a new commentary in The Conversation, making the argument that Medicaid reform is drastically needed and that the best ideas representing both government-administered health insurance and market-based healt ...

May 8, 2017

Lakdawalla's ACO & Emerging Healthcare Delivery Coalition Keynote Summarized by AJMC

In a new article appearing on the AJMC's website, Mary Caffery summarizes Darius Lakdawalla's recent keynote presentation at the AJMC's ACO & Emerging Healthcare Delivery Coalition.

To read the complete article, please click here.

May 5, 2017

PHE’s Stevens and Chou Address Variations in Cost-Effectiveness Studies of PCSK-9 Inhibitors in New Commentary for Journal of Medical Economics

PHE’s Warren Stevens and Jacquelyn Chou, along with coauthor Peter Toth, examine the markedly different cost-effectiveness study results for PCSK-9 inhibitors in a new commentary in the Journal of Medical Economics. The authors attribute the differences primarily to variations in assump ...

May 3, 2017

PHE Paper Selected As Value in Health Editor's Choice Article

We are proud to announce that a recently published paper with PHE co-authors, “Value of Comprehensive HCV Treatment among Vulnerable, High-Risk Populations,” has been selected to be an Editors’ Choice article in the June 2017 issue of Value in Health.

To see the complete article as it ...

May 2, 2017

PHE's ESGC Provides Critical Support to New Legislation, FDA Guidelines

Congratulations to Precision Health Economics, and in particular the Evidence Strategy, Generation, and Communication (ESGC) practice group, for their outstanding efforts in support of the development of new legislation and FDA guidelines allowing biopharmaceutical manufacturers to more proactiv ...

Apr 28, 2017

PHE's Lakdawalla to Deliver Keynote Presentation at AJMC's ACO & Emerging Healthcare Delivery Coalition

PHE Chief Scientific Officer Darius Lakdawalla will deliver the keynote presentation at the AJMC's ACO & Emerging Healthcare Delivery Coalition, to be held May 4th-5th in Scottsdale, Arizona. Dr. Lakdawalla's keynote, to be presented on May 5th, will focus on value frameworks, and provide an eco ...

Apr 27, 2017

Precision’s Blandford in STAT First Opinion: The time for expansion of value-based drug reimbursement is now

Precision’s Larry Blandford offers a new commentary in STAT First Opinion, insisting that payers and the pharmaceutical industry come together to develop a value-based drug reimbursement system. He suggests taking a page from the playbook developed for electronic prescribing as the key to mov ...

Apr 14, 2017

Neumann and Baumgardner in Health Affairs: Balance Needed in Cost-Effectivness Analysis

In a new blog commentary for Health Affairs, PHE's Peter Neumann and James Baumgardner examine the reasons why application of CEA technologies across different types of healthcare interventions are imbalanced, and suggest some possible ways in which the policies of government and private entitie ...

Apr 13, 2017

PHE Scientific Advisor Jena's Study On Delays in Emergency Care During Marathons Picks Up Widespread Coverage

PHE Scientific Advisor Anupam Jena's recent study published in the New England Journal of Medicine focuses on delays in emergency care and mortality in connection to major U.S. marathons. Of note, the study found that on average the time it took patients to get to the hospital during major marat ...

Mar 24, 2017

PHE Authors Awarded 2017 JMCP Award for Excellence

Congratulations to PHE authors Joanna MacEwan, Jason Shafrin, and Darius Lakdawalla who along with co-authors Felicia Forma, Ainslie Hatch and Jean-Pierre Lindenmayer have been awarded the 2017 JMCP Award for Excellence.

The JMCP Award for Excellence is annual award recognizing a single articl ...

Mar 15, 2017

Jena in Harvard Business Review: Higher U.S. Physician Spending Doesn’t Lead to Better Outcomes

In the latest edition of the Harvard Business Review, Precision scientific advisor Anupam Jena along with co-author Yusuke Tsugawa focus on new resaerch showing that higher U.S. physician spending does not lead to better patient outcomes.

To read the complete article, please click here.

Mar 9, 2017

Maclean and Jansen Make the Case for Evidence Synthesis in Clinical Leader

In a new article for Clinical Leader, PHE's Ross Maclean and Jeroen Jansen explain how evidence synthesis can reduce the guesswork of clinical trial design.

To read the complete article, please click here.

Mar 3, 2017

Lakdawalla and Malani Author Two-Part Series on ACA in The Conversation

In a new two-part series featured in The Conversation, PHE's Darius Lakdawalla and co-author Anup Malani provide an ACA primer, as well as look at the landscape of health care reform going forward.

In Part One, Lakdawalla and Malani examine the provisions of the Affordable Care Act, focusing o ...

Feb 20, 2017

"Value of Hope" Study of Patient and Physician Preferences Published in Value in Health

The "Value of Hope" study, examining patient and physician preferences for durable survival, was recently published in a special issue of Value in Health-- focusing on value assessment frameworks.

To read the complete study by PHE authors Jason Shafrin, Taylor Schwartz, John Romley, et al, plea ...

Feb 10, 2017

Shafrin in eyeforpharma: Value-based Pricing’s Time Has Come, and It’s Here to Stay

In "The Price of Everything and the Value of Nothing," PHE Senior Research Economist Jason Shafrin talks prices, politics, and the problem of monopolies with eyeforpharma’s Hugh Gosling.

To read the complete article, please click here.

Feb 9, 2017

Precision To Have Prominent Presence at AMCP Annual Meeting 2017

AMCP is coming to Denver March 27th -30th, and Precision is looking forward to the chance to show off our capabilities and experts with a booth presence, three presentations, four posters and more!

Look for us on the exhibitor floor in Booth 312, and check below for complete information on all ...

Feb 2, 2017

Neumann Discusses Cures Act and New FDA Draft Guidance on Communication

In his latest Health Affairs blog posting, PHE Scientific Advisor Peter Neumann and co-author Elle Pope examine Section 3037 of the Cures Act and new FDA draft guidance, which indicate that drug companies will have expanded flexibility to communicate proactively with payors and formulary committ ...

Jan 31, 2017

PHE Team Author New Study on Medicare Part D Price Controls

In "The Long-Term Impact of Price Controls in Medicare Part D," a new scientific paper recently published in Forum for Health Economics and Policy, PHE authors Gigi Moreno, Emma van Eijndhoven, Jennifer Benner and Jeffrey Sullivan examine the potential impact over time of government price settin ...